# Gesynta Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gesynta-pharma

- Industry: Pharmaceuticals
- Headquarters: Stockholm, Sweden
- Website: www.gesynta.se
- Total disclosed funding: $39M
- Latest round: Series B (Jul 22, 2025)
- Investors on record: 10

## About

Founded in 2017 and based in Sweden, Gesynta Pharma is a pharmaceutical company that develops drug candidates targeting chronic inflammation in various diseases.

## Funding rounds

- Series B, Jul 22, 2025, $4.5M — HealthCap, Hadean Ventures, Innovestor
- Series B, Jan 6, 2025, $27M — Industrifonden, Hadean Ventures, Innovestor, Stephen Industries, Amboy Street Ventures, Linc AB, RH Capital, Foreground Capital, Catalyze Capital
- Seed, Apr 4, 2019, $6.7M — Industrifonden

## Investors

- Industrifonden (https://capitalatlas.ai/funds/industrifonden) — Seed, Series B
- Hadean Ventures (https://capitalatlas.ai/funds/hadean-ventures) — Series B
- Innovestor (https://capitalatlas.ai/funds/innovestor) — Series B
- Stephen Industries — Series B
- Amboy Street Ventures (https://capitalatlas.ai/funds/amboy-street-ventures) — Series B
- Linc AB — Series B
- RH Capital — Series B
- Foreground Capital (https://capitalatlas.ai/funds/foreground-capital) — Series B
- Catalyze Capital (https://capitalatlas.ai/funds/catalyze-capital) — Series B
- HealthCap — Series B